Synapse - Works

Results (2899)

Efficacy of brentuximab vedotin maintenance therapy following autologous stem cell transplantation in patients with relapsed/refractory classical Hodgkin lymphoma with and without pre-transplant exposure to novel agents

Meeting Abstract

Falade, A. S.; Redd, R. A.; Shah, H.; Baron, K.; Iyengar, S.; Desai, S. H.; Ansell, S. M.; Micallef, I.; Nedved, A.; Ganesan, N.; more...
Blood (2023)

Fulltext@MSK | Save

Trial in progress: Patient-reported outcome measures in the prospective observational cohort study of patients at risk for chronic graft-versus-host disease in the United States (THRIVE)

Meeting Abstract

Ponce, D. M.; El-Jawahri, A.; Hamilton, B. K.; Khera, N.; Bhatt, V.; Galvin, J.; Lee, C. J.
Blood (2023)

Fulltext@MSK | Save

"Defining the optimal post-CART monitoring period in recipients of axicabtagene ciloleucel and tisagenlecleucel"

Meeting Abstract

Wesson, W.; Lutfi, F.; Porter, D. L.; Bachanova, V.; Nastoupil, L. J.; Riedell, P. A.; Perales, M. A.; Maziarz, R. T.; Brower, J.; Shah, G. L.; more...
Blood (2023)

Fulltext@MSK | Save

Preliminary safety results of the open-label phase of a 2-part phase 1b study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of an investigational microbiome therapeutic, SER-155, in adults undergoing hematopoietic cell transplantation

Meeting Abstract

Ponce, D. M.; Kosuri, S.; Khera, N.; Defilipp, Z.; Lichter, D. I.; Peled, J. U.; van den Brink, M. R. M.; Brady, K.; Puhl, M. D.; Glick, G.; more...
Blood (2023)

Fulltext@MSK | Save

Outcomes of patients with primary mediastinal B-cell lymphoma refractory or relapsed after frontline R-EPOCH chemotherapy

Meeting Abstract

Bakos, J.; Escribano Serrat, S.; Sawalha, Y.; Moskowitz, A.; Crawford, A.; Brooks, T. R.; Hill, B. T.; Falade, A. S.; Merryman, R. W.; Kamdar, M.; more...
Blood (2023)

Fulltext@MSK | Save

Comparison of bendamustine versus fludarabine/cyclophosphamide lymphodepletion in adult patients receiving CD19 CAR-T cell therapy

Meeting Abstract

Landego, I.; Nemirovsky, D.; Devlin, S. M.; Wills, B.; Parascondola, A.; Saldia, A.; Dahi, P. B.; Tomas, A. A.; Ip, A.; Suh, H. C.; more...
Blood (2023)

Fulltext@MSK | Save

Patterns and safety of glucocorticosteroids use following CD19 CAR-T cell therapy for B-cell lymphoma

Meeting Abstract

Luttwak, E.; Flynn, J. R.; Devlin, S. M.; Cassanello, G.; Corona, M.; Dahi, P. B.; Luna De Abia, A.; Fein, J.; Giralt, S. A.; Landego, I.; more...
Blood (2023)

Fulltext@MSK | Save

The impact of cardiovascular vulnerabilities in non Hodgkin lymphoma patients treated with chimeric antigen receptor T cell therapy

Meeting Abstract

Landego, I.; Flynn, J. R.; Goldman, A.; Devlin, S. M.; Luttwak, E.; Luna De Abia, A.; Corona, M.; Kedmi, M.; Sdayoor, I.; Fried, S.; more...
Blood (2023)

Fulltext@MSK | Save

First fever between lymphodepletion and day 30 after CAR-T cell therapy: Patterns, origins, and implications in lymphoma patients

Meeting Abstract

Melica, G.; Luna, A.; Fei, T.; Corona, M.; Dahi, P. B.; Fein, J.; Giralt, S. A.; Raj, S.; Landego, I.; Lin, R. J.; more...
Blood (2023)

Fulltext@MSK | Save

Detection of CAR-T cell persistence with digital droplet PCR: Correlation of in vivo expansion with clinical outcomes in a cohort of B-cell lymphoma patients

Meeting Abstract

Cassanello, G.; Borsu, L.; Arcila, M. E.; Yao, J.; Boroujeni, A. M.; Ewalt, M.; Patel, U.; Chan, R.; Gray, B.; Luna De Abia, A.; more...
Blood (2023)

Fulltext@MSK | Save